Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,740,239,592
-
Total 13F shares
-
1,373,457,328
-
Share change
-
+26,944,397
-
Total reported value
-
$186,724,601,473
-
Put/Call ratio
-
83%
-
Price per share
-
$136.01
-
Number of holders
-
3,151
-
Value change
-
+$3,689,370,235
-
Number of buys
-
1,450
-
Number of sells
-
1,332
Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2025
As of 30 Jun 2025,
ABBOTT LABORATORIES - Common Stock (ABT) was held by
3,151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,373,457,328 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, Capital International Investors, Capital Research Global Investors, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, and NORGES BANK.
This page lists
3,160
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.